{"url":"https://lda.senate.gov/api/v1/filings/9a25ce1b-95b9-4eec-9e92-3d9fb63cb4fc/","filing_uuid":"9a25ce1b-95b9-4eec-9e92-3d9fb63cb4fc","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2010,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/9a25ce1b-95b9-4eec-9e92-3d9fb63cb4fc/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"George Olsen, Principal","dt_posted":"2011-01-20T14:18:27.580000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"701 8th Street, NW","registrant_address_2":"Suite 500","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":41454,"url":"https://lda.senate.gov/api/v1/registrants/41454/","house_registrant_id":30771,"name":"WILLIAMS AND JENSEN, PLLC","description":"Lobbying Law Firm","address_1":"1201 Pennsylvania Avenue, NW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ISABELLA QUINN","contact_telephone":"+1 202-659-8201","dt_updated":"2026-04-17T15:06:36.274151-04:00"},"client":{"id":151462,"url":"https://lda.senate.gov/api/v1/clients/151462/","client_id":1005724,"name":"CEPHALON INC.","general_description":"biopharmaceutical company","client_government_entity":false,"client_self_select":false,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-10-01"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Legislation concerning patent settlements between brand name and generic pharmaceutical companies including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs; and FY 2011 Financial Services and General Government Appropriations bill.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":18077,"prefix":null,"prefix_display":null,"first_name":"GEORGE","nickname":null,"middle_name":null,"last_name":"OLSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":37173,"prefix":null,"prefix_display":null,"first_name":"KARINA","nickname":null,"middle_name":null,"last_name":"LYNCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36102,"prefix":"ms","prefix_display":"MS.","first_name":"JOYCE","nickname":null,"middle_name":"A","last_name":"ROGERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":2976,"prefix":null,"prefix_display":null,"first_name":"JENNY","nickname":null,"middle_name":null,"last_name":"DIJAMES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}